Accessibility Menu
 
Therapeutic Solutions International logo

Therapeutic Solutions International

(OTC) TSOI

Current Price$0.00
Market Cap$5,100
Since IPO (2011)-100%
5 Year-100%
1 Year-100%
1 Month+0%

Therapeutic Solutions International Financials at a Glance

Market Cap

$5,100

Revenue (TTM)

$85.32K

Net Income (TTM)

$2.41M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-15.71 (Low)

Price

$0.00

Volume

12,600

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

TSOI News

No articles available.

TSOI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Therapeutic Solutions International

Industry

Pharmaceuticals

Employees

3

CEO

Timothy G. Dixon

Headquarters

Elk City, ID 83525, US

TSOI Financials

Key Financial Metrics (TTM)

Gross Margin

63%

Operating Margin

-20%

Net Income Margin

-22%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-66%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.10K

Shares Outstanding

5.12B

Volume

12.60K

Short Interest

0.00%

Avg. Volume

153.76K

Financials (TTM)

Gross Profit

$62.23K

Operating Income

$1.99M

EBITDA

$1.49M

Operating Cash Flow

$1.06M

Capital Expenditure

$16.16K

Free Cash Flow

$1.07M

Cash & ST Invst.

$27.82K

Total Debt

$888.06K

Therapeutic Solutions International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$19.67K

-99.9%

Gross Profit

$15.26K

-99.9%

Gross Margin

77.58%

N/A

Market Cap

$5.10K

N/A

Market Cap/Employee

$1.70K

N/A

Employees

3

N/A

Net Income

$1.01M

+99.8%

EBITDA

$1.85M

-318.2%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$920.39K

-15.2%

Accounts Receivable

$17.04K

-21.7%

Inventory

$17.15K

-35.1%

Long Term Debt

$80.18K

-28.3%

Short Term Debt

$849.45K

+9.3%

Return on Assets

-65.91%

N/A

Return on Invested Capital

-1.43%

N/A

Free Cash Flow

$70.84K

+121.6%

Operating Cash Flow

$70.84K

+122.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BNGIBangi Inc.
$0.00+0.00%
MCETMultiCell Technologies, Inc.
$0.00+0.00%
PFNDPathfinder Cell Therapy, Inc.
$0.00+0.00%
BPTSYBiophytis S.A.
$0.45-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About TSOI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.